Abstract is: Peripheral T-cell lymphoma refers to a group of T-cell lymphomas that develop away from the thymus or bone marrow. Examples include: * Cutaneous T-cell lymphomas * Angioimmunoblastic T-cell lymphoma * Extranodal natural killer/T-cell lymphoma, nasal type * Enteropathy type T-cell lymphoma * Subcutaneous panniculitis-like T-cell lymphoma * Anaplastic large cell lymphoma * Peripheral T-cell lymphoma-Not-Otherwise-Specified In ICD-10, cutaneous T-cell lymphomas are classified separately.
| class of disease | Q112193867 |
| mature T-cell and NK-cell lymphoma | Q18553445 |
| P699 | Disease Ontology ID | DOID:0050749 |
| P10565 | Encyclopedia of China (Third Edition) ID | 559453 |
| P2888 | exact match | http://identifiers.org/doid/DOID:0050749 |
| http://purl.obolibrary.org/obo/DOID_0050749 | ||
| P4317 | GARD rare disease ID | 7368 |
| P494 | ICD-10 ID | C84.4 |
| P4229 | ICD-10-CM | C84.4 |
| P493 | ICD-9 ID | 202.7 |
| P665 | KEGG ID | H01892 |
| P486 | MeSH descriptor ID | D016411 |
| P672 | MeSH tree code | C04.557.386.480.750.825 |
| C15.604.515.569.480.750.825 | ||
| C20.683.515.761.480.750.825 | ||
| P6366 | Microsoft Academic ID | 2777891184 |
| P5270 | Mondo ID | MONDO_0000434 |
| P10283 | OpenAlex ID | C2777891184 |
| P4233 | PatientsLikeMe condition ID | peripheral-t-cell-lymphoma |
| P2892 | UMLS CUI | C0079774 |
| P11143 | WikiProjectMed ID | Peripheral T-cell lymphoma |
| P1995 | health specialty | oncology | Q162555 |
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| Q42629340 | A Herpes saimiri oncogene causing peripheral T-cell lymphoma in transgenic mice. |
| Q44493928 | A Rare Case of Primary Gastric HIV-Associated Peripheral T-Cell Lymphoma: Relapsed Disease Treated With Pemetrexed |
| Q86241676 | A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy |
| Q50754187 | A case of CD8(+) primary cutaneous peripheral T-cell lymphoma arising from tissue-resident memory T cells in the skin. |
| Q35621159 | A case of childhood peripheral T-cell lymphoma with massive cardiac infiltration |
| Q43414642 | A case of melena and perforation during chemotherapy for peripheral T-cell lymphoma, not otherwise specified of the small intestine |
| Q45782399 | A case of neural cell adhesion molecule-positive peripheral T-cell lymphoma associated with human T-cell lymphotrophic virus type 1 showing an unusual involvement of the gastrointestinal tract during the course of the disease |
| Q85610833 | A case of peripheral T-cell lymphoma presenting with acute liver failure |
| Q50761033 | A case of peripheral T-cell lymphoma unspecified involving subcutaneous tissue. |
| Q36666226 | A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology |
| Q49681443 | A case of peripheral T-cell lymphoma, not otherwise specified, with rapid progression to erythroderma |
| Q58582994 | A case of primary cutaneous peripheral T-cell lymphoma, not otherwise specified with cytotoxic phenotype showing multiple ulcers on the entire body |
| Q41291090 | A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy |
| Q43765534 | A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study. |
| Q55241717 | A pathologic study of childhood lymphoma in Taiwan with special reference to peripheral T-cell lymphoma and the association with Epstein-Barr viral infection. |
| Q92652485 | A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature |
| Q91234205 | A peripheral cause of asthma: Peripheral T-cell lymphoma |
| Q45051052 | A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma |
| Q33428066 | A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial |
| Q95381194 | A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial |
| Q33431457 | A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients |
| Q95501938 | A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial) |
| Q41956081 | A poor prognostic case of peripheral T-cell lymphoma in the base of tongue with chemotherapy followed by radiation therapy |
| Q40444551 | A prospective cohort study of patients with peripheral T-cell lymphoma in the United States |
| Q82706769 | A rare case of Lennert's type peripheral T-cell lymphoma with t(14;19)(q11.2;q13.3) |
| Q35931553 | A rare case of peripheral T-cell lymphoma in 1-year-old child. |
| Q54409199 | A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission. |
| Q87022506 | A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group |
| Q34589970 | ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project |
| Q47366063 | ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified |
| Q46836814 | Abdominal subcutaneous nodules with florid granulomatous reaction in a 53-year-old woman. Peripheral T-cell lymphoma, unspecified |
| Q91780873 | Aberrant CD3-Positive, CD8-Low, CD7-Negative Lymphocytes May Appear During Viral Infections and Mimic Peripheral T-Cell Lymphoma |
| Q52782304 | Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue. |
| Q84212911 | Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vβ repertoire |
| Q60302124 | Acrokeratosis paraneoplastica (Bazex syndrome) associated with peripheral T-cell lymphoma |
| Q77674342 | Acrokeratosis paraneoplastica (Bazex's syndrome): unusual association with a peripheral T-cell lymphoma |
| Q90601647 | Activated-cytotoxic TCRαβ+CD4+ peripheral T-cell lymphoma with hypodermal localization: Case report of a lymphoproliferative disorder probably evolved from the CD4+ cytotoxic T-cell subpopulation |
| Q39608513 | Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis. |
| Q34391540 | Acute liver failure as a rare initial manifestation of peripheral T-cell lymphoma |
| Q90014040 | Aggressive CD4-CD8-CD45RA+CCR10- Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report |
| Q42198778 | Aggressive Subcutaneous Panniculitis-Like CD30+ Peripheral T-Cell Lymphoma with Diffuse EBER Expression. |
| Q73357768 | Aggressive gastric peripheral T-cell lymphoma of CD8+ type associated with lymphomatous meningitis |
| Q43588217 | Aggressive peripheral T-cell lymphoma containing Epstein-Barr virus genomes |
| Q44195595 | Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. |
| Q46124726 | Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study |
| Q94550714 | Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial |
| Q46375397 | Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response. |
| Q92954608 | Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma |
| Q102063583 | Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome |
| Q38253436 | Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis |
| Q47586189 | Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions |
| Q67962630 | An identical chromosome abnormality: der(6)t(6;7)(q13;p13) in two patients with peripheral T-cell lymphoma |
| Q54673570 | An unusual case of peripheral T-cell lymphoma with CD56 positivity and angiocentric, angiodestructive morphology arising in the ileum. |
| Q35683871 | An update on the management of peripheral T-cell lymphoma and emerging treatment options |
| Q38956577 | Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States |
| Q95381202 | Analysis of peripheral T-cell lymphoma (PTCL) subtype by race and geography using the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) dataset |
| Q43254038 | Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy |
| Q54692504 | Anaplastic large-cell lymphoma and peripheral T-cell lymphoma: What can pediatricians and adult oncologists learn from each other? |
| Q40604686 | Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile |
| Q36718543 | Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process. |
| Q41841292 | Anorectal and gastric peripheral T-cell lymphoma, unspecified in a non-AIDS patient |
| Q73585735 | Anti-phospholipid-antibody syndrome associated with peripheral T-cell lymphoma |
| Q91708581 | Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype |
| Q41198594 | Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data |
| Q90814823 | Atypical Histiocytic Lesion Preceding a Peripheral T-Cell Lymphoma Involving the Skin Exhibiting the Same Molecular Alterations |
| Q39551660 | Atypical presentation of isolated peripheral T-cell lymphoma in the hand: case report |
| Q44588425 | Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen |
| Q44369398 | Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype |
| Q38949798 | Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience |
| Q35608203 | Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. |
| Q97561919 | Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival |
| Q89749871 | Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial |
| Q60907239 | Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma |
| Q96587185 | Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma |
| Q99612630 | Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL) |
| Q95385612 | Belinostat (Beleodaq) for peripheral T-Cell lymphoma |
| Q33423816 | Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study. |
| Q26796449 | Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review |
| Q46629443 | Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development |
| Q92008555 | Bilateral breast adenopathy-A rare presentation of peripheral T-cell lymphoma |
| Q68506226 | Bilateral orbital infiltration as the initial sign of a peripheral T-cell lymphoma presenting in a leukemic phase |
| Q80789032 | Bilateral peripheral T-cell lymphoma of breast: a case report |
| Q81101683 | Bilateral peripheral T-cell lymphoma of the fallopian tubes |
| Q110661771 | Biomarker Quality Assurance (QA) Findings From the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) Registry |
| Q51161466 | Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients. |
| Q53457702 | Bizarre‐looking violaceous nodular plaque on the hands: Unusual presentation of peripheral T‐cell lymphoma, not otherwise specified |
| Q90711557 | Body mass index at diagnosis is associated with survival outcome in peripheral T-cell lymphoma: a study of Chinese population |
| Q73367592 | Bone marrow fibrin-ring (doughnut) granulomas and peripheral T-cell lymphoma: an exceptional association |
| Q61053547 | Bone marrow histologic and immunohistochemical findings in peripheral T-cell lymphoma: A study of 38 cases |
| Q87409325 | Bone marrow involvement as initial presentation of CD8 cytotoxic peripheral T-cell lymphoma with CD20 coexpression and relatively indolent clinical course |
| Q67948755 | Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents |
| Q104481812 | Breast Implant-Associated CD30 Negative Peripheral T-Cell Lymphoma, NOS |
| Q90315270 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial |
| Q73793833 | CD-30 positive peripheral T-cell lymphoma of the Waldeyer's ring |
| Q34098570 | CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature |
| Q64039862 | CD20-positive and CD4/CD8-double-negative peripheral T-cell lymphoma of spleen complicated with severe disseminated intravascular coagulation and enteropathy |
| Q91087458 | CD20-positive primary nasal peripheral T-cell lymphoma: An analysis of one case and review of the literature |
| Q91058914 | CD3 and CD20 co-expression in a case of canine peripheral T-cell lymphoma with prominent cardiac and peripheral nerve involvement |
| Q95448749 | CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases |
| Q58001073 | CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland |
| Q58482193 | CD30-Positive Multilobated Peripheral T-Cell Lymphoma Primarily Involving the Subcutaneous Tissue |
| Q51438121 | CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? |
| Q45155728 | CD56-positive peripheral T-cell lymphoma primarily presenting with tonsillar swelling |
| Q86610583 | CD8+ primary cutaneous peripheral T-cell lymphoma in an 18-year-old woman |
| Q57279263 | CD8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrentin situfollicular lymphoma |
| Q82404936 | CD8-positive primary cutaneous peripheral T-cell lymphoma, unspecified |
| Q100544850 | CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) |
| Q41246604 | CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin |
| Q53828417 | CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. |
| Q38002186 | CT features of peripheral T-cell lymphoma in the gastrointestinal tract in Chinese population and literature review. |
| Q53658155 | CT findings in peripheral T-cell lymphoma involving the gastrointestinal tract. |
| Q54704598 | CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. |
| Q48134602 | Case of peripheral T-cell lymphoma, not otherwise specified, presenting dyshidrosis-like eruptions as the first clinical manifestation |
| Q87845594 | Case of primary cutaneous peripheral T-cell lymphoma, not otherwise specified, with characteristics of follicular helper T cells |
| Q84512739 | Central nervous system prophylaxis in peripheral T-cell lymphoma |
| Q53661958 | Cervical presentation of peripheral T-cell lymphoma not otherwise specified. |
| Q50628545 | Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice. |
| Q39110404 | Chidamide in the treatment of peripheral T-cell lymphoma |
| Q61312223 | Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma |
| Q68830514 | Chromosome abnormalities in peripheral T-cell lymphoma |
| Q73506445 | Chromosome abnormalities in peripheral T-cell lymphoma |
| Q64892355 | Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells. |
| Q53288159 | Circulating reactive plasma cells in the setting of peripheral T-cell lymphoma mimicking plasma cell leukemia. |
| Q51595914 | Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis. |
| Q35958818 | Clinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphoma |
| Q31092020 | Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data |
| Q82616863 | Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion |
| Q51369599 | Clinical and radiological CLIPPERS features after complete remission of peripheral T-cell lymphoma, not otherwise specified. |
| Q33382121 | Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project |
| Q31105027 | Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG). |
| Q46826749 | Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases |
| Q92683898 | Clinical significance of enhancer of zeste homolog 2 and histone deacetylases 1 and 2 expression in peripheral T-cell lymphoma |
| Q37722893 | Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan |
| Q46701309 | Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. |
| Q55241290 | Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese. |
| Q40363454 | Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan |
| Q88727382 | Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified |
| Q53073971 | Clonal identity and histologic difference in peripheral T-cell lymphoma with follicular helper T-cell phenotype simultaneously occurring at common bile duct and lymph nodes. |
| Q36175172 | Clonal rearrangements and Malignant Clones in Peripheral T-cell Lymphoma |
| Q93088267 | Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified |
| Q47147843 | Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy |
| Q52573979 | Coexistence of neocentromeric marker 3q and trisomy 3 in two different tissues in a 3-year-old boy with peripheral T-cell lymphoma: support for a gene dosage effect hypothesis. |
| Q84265234 | Coexistence of spinal schwannoma with unusual malignant peripheral T-cell lymphoma within a lumbar spine lesion |
| Q104474624 | Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide (ICE) in relapsed/refractory peripheral T-cell lymphoma |
| Q33428567 | Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study |
| Q86946168 | Combination therapy for relapsed peripheral T-cell lymphoma: is two better than one? |
| Q64092499 | Comment to "The outcome of peripheral T-cell lymphoma patients failing first-line therapy" |
| Q36757396 | Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma |
| Q57184869 | Comparative Clinicopathological Analysis of Cutaneous Peripheral T-cell lymphoma, Not Otherwise Specified, According to Primary Tumor Site |
| Q40615052 | Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1. |
| Q79920789 | Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis |
| Q64108350 | Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis |
| Q48303194 | Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified |
| Q92578081 | Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma |
| Q50089720 | Composite CD20-positive T-cell lymphoma and peripheral T-cell lymphoma, NOS: report of a case |
| Q36637659 | Composite EBV negative peripheral T-cell lymphoma and diffuse large B-cell lymphoma involving the ileum: a case report and a systematic review of the literature |
| Q93022251 | Composite Lymphoma Containing Mantle Cell and Peripheral T-cell Lymphoma, Not Otherwise Specified: A Report of 2 Cases Treated With Up-front Autologous Stem Cell Transplantation |
| Q36359289 | Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein-Barr virus: a case report and review of the literature |
| Q36278227 | Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis |
| Q40401205 | Composite lymphoma: EBV-positive classic Hodgkin lymphoma and peripheral T-cell lymphoma: a case report |
| Q38058080 | Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis. |
| Q45365520 | Composite primary cutaneous peripheral T-cell lymphoma and Epstein-Barr virus-positive large B-cell lymphoma. |
| Q68831780 | Concurrent multicentric angiofollicular lymph node hyperplasia and peripheral T-cell lymphoma |
| Q96028386 | Contemporary strategies to improve outcomes for peripheral T-cell lymphoma patients following the failure of first-line therapy |
| Q100661014 | Controversies in the Treatment of Peripheral T-cell Lymphoma |
| Q91482697 | Corneal Relapse of Peripheral T-Cell Lymphoma Under Systemic Chemotherapy |
| Q90496994 | Correction: Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma |
| Q90317678 | Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified |
| Q102992109 | Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial |
| Q90818203 | Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: A case report |
| Q110662007 | Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404) |
| Q37341209 | Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. |
| Q59195996 | Cutaneous Anaplastic Large Cell Lymphoma and Peripheral T-Cell Lymphoma NOS Show Distinct Chromosomal Alterations and Differential Expression of Chemokine Receptors and Apoptosis Regulators |
| Q35004729 | Cutaneous involvement in the lymphoepithelioid variant of peripheral T-cell lymphoma, unspecified (Lennert lymphoma). Report of a case and review of the literature |
| Q53590326 | Cutaneous manifestations of peripheral T-cell lymphoma, not otherwise specified: a case series highlighting the diagnostic challenges for this heterogeneous group. |
| Q36910340 | Cutaneous manifestations of unspecified peripheral T-cell lymphoma may be indicative of disease activity and predict response to therapy. |
| Q54481138 | Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. |
| Q40336585 | Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma |
| Q38921120 | Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis |
| Q38519293 | Cutaneous relapse of angioimmunoblastic lymphadenopathy‐type peripheral T‐cell lymphoma mimicking an exanthematous drug eruption |
| Q80874484 | Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma |
| Q68803279 | Cytogenetic abnormalities in noncutaneous peripheral T-cell lymphoma |
| Q61312350 | Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma |
| Q68918935 | Cytogenetic findings in 21 cases of peripheral T-cell lymphoma |
| Q73975247 | Cytologic diagnosis of peripheral T-cell lymphoma manifesting as ascites. A case report |
| Q21245025 | Cytologic findings of peripheral T-cell lymphoma (PTCL) with high epitheloid cell content (Lennert's lymphoma) in imprint smear. A case report |
| Q38521854 | Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature |
| Q35528650 | Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type |
| Q81000777 | De novo maintenance therapy with denileukin diftitox (Ontak) in a patient with peripheral T-cell lymphoma is associated with prolonged remission |
| Q88797016 | Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma |
| Q93131811 | Defining the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression profiling assay (RT-MLPA) |
| Q80273652 | Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma |
| Q41935057 | Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment |
| Q28070073 | Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China |
| Q91111865 | Development of new agents for peripheral T-cell lymphoma |
| Q38097336 | Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrier |
| Q34080766 | Diagnosis of peripheral T-cell lymphoma by fine-needle aspiration biopsy: a cytomorphologic and immunophenotypic approach |
| Q92478137 | Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma |
| Q69500310 | Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately? |
| Q51873013 | Discordant lymphocyte-depleted classical Hodgkin's and peripheral T-cell lymphoma arising in a patient 11 years after diagnosis of multicentric Castleman's disease. |
| Q40106418 | Discordant lymphoma of duodenal EBV-positive peripheral T-cell lymphoma not otherwise specified and ileal diffuse large B-cell lymphoma |
| Q48161577 | Disease site as a determinant of survival outcome in patients with primary cutaneous peripheral T-cell lymphoma, unspecified: an analysis of 4057 cases from the US National Cancer Database. |
| Q53247017 | Disseminated tuberculosis following unrelated cord blood transplantation for refractory peripheral T-cell lymphoma: Clinical role of serum procalcitonin levels. |
| Q53304621 | Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity |
| Q84451076 | Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma |
| Q53738710 | Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement. |
| Q40708207 | EBV-associated Peripheral T-Cell Lymphoma of Gastrointestinal Tract Presented With Widespread Chronic Inflammation: A Case Report |
| Q45793403 | EBV-driven relapse of peripheral T-cell lymphoma, masquerading as a post transplant lymphoproliferative disorder following allo-SCT. |
| Q41561570 | EBV-positive peripheral T-cell lymphoma with extensive hemophagocytosis |
| Q49242230 | Early diagnosis of an isolated primary peripheral T-cell lymphoma masquerading as massive gingival enlargement in a pediatric patient |
| Q92235371 | Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate |
| Q91901185 | Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma |
| Q35064709 | Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma |
| Q91752030 | Emerging strategies in peripheral T-cell lymphoma |
| Q47133172 | Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas |
| Q38784407 | Endoscopic detection of the gastric lesions of peripheral T-cell lymphoma |
| Q64232257 | Endoscopic mucosal resection for diagnosis of peripheral T-cell lymphoma arising in the duodenum |
| Q36141832 | Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma |
| Q34184665 | Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. |
| Q79916818 | Eosinophilic fasciitis, myositis and arthritis as early manifestations of peripheral T-cell lymphoma |
| Q91177732 | Eosinophilic granulomatosis with polyangiitis mimicking peripheral T-cell lymphoma, not otherwise specified |
| Q101450774 | Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma |
| Q42681555 | Epstein-Barr Virus-Associated Peripheral T-Cell Lymphoma involving Spleen in a Renal Transplant Patient |
| Q45416664 | Epstein-Barr virus (EBV)-associated aggressive peripheral T-cell lymphoma showing folliculotropism |
| Q45050902 | Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified |
| Q40533056 | Epstein-Barr virus-associated composite lymphoma composed of peripheral T-cell lymphoma and an anaplastic variant of a diffuse large B-cell type of non-Hodgkin's lymphoma and strongly expressing p53 protein |
| Q45361394 | Epstein-Barr virus-associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T-cell lymphoma 9 years later: a case report of composite lymphoma |
| Q35910738 | Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature |
| Q44223814 | Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions |
| Q45850601 | Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype |
| Q40545120 | Epstein-Barr virus-associated peripheral T-cell lymphoma with gastrointestinal tract involvement. |
| Q42834412 | Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case |
| Q85350956 | Erratum to: Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab |
| Q93562780 | Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma |
| Q53436880 | Establishment of a peripheral T-cell lymphoma cell line showing amplification of the c-myc oncogene. |
| Q81969753 | Evaluation of FoxP3 expression in peripheral T-cell lymphoma |
| Q98949627 | Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma |
| Q89467484 | Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphoma |
| Q83709913 | Evans syndrome with cytomegalovirus infection followed by emerging peripheral T-cell lymphoma |
| Q43485092 | Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis |
| Q36612584 | Evolving Therapy of Peripheral T-cell Lymphoma: 2010 and beyond |
| Q54560297 | Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules. |
| Q28301361 | Expression of CD52 in peripheral T-cell lymphoma |
| Q51887618 | Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis. |
| Q83817535 | Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified |
| Q81799233 | Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified |
| Q53164165 | Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified |
| Q67960706 | Extensive hepatic granulomas associated with peripheral T-cell lymphoma |
| Q47685849 | Extranodal CD20-positive peripheral T-cell lymphoma presenting with adrenal and testicular masses. |
| Q73457694 | Extranodal peripheral T-cell lymphoma with angiocentric growth pattern and Epstein-Barr viral DNA associated affecting paratesticular soft tissue |
| Q74342739 | Extranodal peripheral T-cell lymphoma: report of a case with unusual presentation |
| Q39100902 | Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era. |
| Q95298491 | Failure of Romidepsin to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma in Children: A Single-center Experience |
| Q64049785 | Fatal peripheral T-cell lymphoma following intramuscular tuberculosis of the forearm |
| Q95563586 | First Multicenter, Randomized Phase 3 Study in Patients (Pts) With Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL): Alisertib (MLN8237) Versus Investigator's Choice (LUMIERE trial; NCT01482962) |
| Q48639910 | First case report of a peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child |
| Q37271019 | First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation |
| Q38052774 | Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics |
| Q37866366 | Follicular variant of peripheral T-cell lymphoma mimicking follicular lymphoma: a case report with a review of the Literature |
| Q33391588 | Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: U.S. Food and Drug Administration Drug Approval Summary |
| Q44876649 | Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified |
| Q54964939 | Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review. |
| Q88419445 | Frequency, distribution, and immunomorphologic characteristics of peripheral T-cell lymphoma, not otherwise specified in a tertiary care center in Southern India |
| Q82480443 | Frontline autologous stem cell transplantation for peripheral T-cell lymphoma |
| Q28307793 | Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group |
| Q42664840 | Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation. |
| Q61868116 | Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience |
| Q90398593 | Gemcitabine, cisplatin, prednisone, and thalidomide for relapse and refractory peripheral T-cell lymphoma: a retrospective study from China |
| Q104736303 | Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma |
| Q33405000 | Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma |
| Q44514637 | Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. |
| Q33585243 | Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma |
| Q91723445 | Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma |
| Q45765962 | Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area |
| Q35098010 | Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations |
| Q97423469 | Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine |
| Q72811125 | Granulocytic sarcoma: an immunohistologic comparison with peripheral T-cell lymphoma in paraffin sections |
| Q92399471 | Granuloma formation clinically presenting as erythroderma in a patient with peripheral T-cell lymphoma |
| Q41682425 | Guillain-Barré syndrome and severe infection following chemotherapy for peripheral T-cell lymphoma: A case report |
| Q41738374 | HIV-associated peripheral T-cell lymphoma with a cytotoxic phenotype |
| Q102053293 | Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis |
| Q89711058 | Hematoma-like primary cutaneous peripheral T-cell lymphoma: a rare clinical presentation |
| Q40094366 | Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma: a case report |
| Q82660922 | Hemophagocytosis and relapsed peripheral T-cell lymphoma |
| Q40652579 | Hepatic peripheral T-cell lymphoma: a spectrum of liver pathology and clinical correlation. |
| Q28212003 | Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type |
| Q91750309 | High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study |
| Q92253988 | High activation of STAT5A drives peripheral T-cell lymphoma and leukemia |
| Q53294613 | High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience. |
| Q34228365 | High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone |
| Q40571175 | High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. |
| Q53579933 | High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival. |
| Q44663952 | High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience |
| Q44525952 | High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis |
| Q28554530 | Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review |
| Q64274976 | Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas |
| Q50117976 | Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified |
| Q45741307 | Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection |
| Q41642740 | Hodgkin-like peripheral T-cell lymphoma (PTCL) with preserved Hodgkin-like lesions at autopsy: a case report with an interesting clinical course |
| Q91951343 | Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma |
| Q50997823 | Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations. |
| Q33702340 | IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma |
| Q100296044 | Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma |
| Q36530784 | Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations |
| Q40790522 | Immunoblastic peripheral T-cell lymphoma confined to bone marrow in an infant presenting with aspergillosis |
| Q55242322 | Immunohistochemical analysis of peripheral T-cell lymphoma in Japanese patients. |
| Q44799525 | Immunologic characterization of lymphoid tumor cells from adult T-cell leukemia (ATL) and peripheral T-cell lymphoma (PTCL) in an ATL-endemic area |
| Q49929713 | Immunophenotype Expression Change From CD52+ to CD52- on Erythrodermic Peripheral T-cell Lymphoma, Not Otherwise Specified After Treatment With Alemtuzumab |
| Q46236674 | Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States |
| Q57641823 | Incidental Detection of Shoulder Peripheral T-Cell Lymphoma During the Redistribution Phase of 201Tl Myocardial Perfusion Scintigraphy |
| Q42242569 | Indolent peripheral T-cell lymphoma involving the gastrointestinal tract |
| Q92096777 | Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma |
| Q28270332 | Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma |
| Q68368488 | Interleukin 4 and gamma-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma |
| Q64093793 | Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells |
| Q96604413 | Intradural extramedullary relapse of peripheral T-cell lymphoma, NOS |
| Q57301213 | Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature |
| Q91173565 | JSH practical guidelines for hematological malignancies, 2018: 7. Peripheral T-cell lymphoma (PTCL) |
| Q42278896 | Keratitis-Ichthyosis-Deafness Syndrome, Atypical Connexin GJB2 Gene Mutation, and Peripheral T-Cell Lymphoma: More Than a Random Association? |
| Q42800743 | L-Asparaginase-Induced Complete Response in a Relapsed Patient with Epstein-Barr Virus and Cytotoxic Peripheral T-Cell Lymphoma Not Otherwise Specified |
| Q33726989 | Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma |
| Q53271214 | Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis. |
| Q33430525 | Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study |
| Q58482092 | Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified |
| Q77389277 | Leprosy with peripheral T-cell lymphoma: a rare association |
| Q67493522 | Lethal midline granuloma (peripheral T-cell lymphoma) after lymphomatoid papulosis |
| Q68813911 | Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma |
| Q46459439 | Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation. |
| Q45929976 | Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. |
| Q98507833 | Lost in the Clinics and Found in the Morgue: A Case of Peripheral T-cell Lymphoma Masquerading as Pneumonia |
| Q68872584 | Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma |
| Q40574914 | Lymph node lesion in adult-onset Still's disease resembling peripheral T-cell lymphoma: a report of three cases |
| Q75356980 | Lymphadenopathy in adult-onset Still's disease mimicking peripheral T-cell lymphoma |
| Q53105614 | Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman. |
| Q85044973 | Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified |
| Q35207251 | Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy |
| Q67809836 | Magnetic resonance imaging of peripheral T-cell lymphoma |
| Q40331158 | Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score |
| Q41717228 | Mediastinal peripheral T-cell lymphoma diagnosed by repeated biopsies after an initial diagnosis of fibrosing mediastinitis |
| Q92705289 | Mediastinal peripheral T-cell lymphoma presenting with hematemesis |
| Q86945381 | Meeting an unmet need for peripheral T-cell lymphoma |
| Q54643577 | Metachronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and peripheral T-cell lymphoma unspecified: histologic, immunophenotypic, and molecular documentation. |
| Q52919265 | MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified. |
| Q41816496 | Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report |
| Q37708848 | Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes. |
| Q90819689 | Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma |
| Q73373458 | Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay |
| Q92052628 | Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling |
| Q36123511 | Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case report |
| Q33634415 | Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma |
| Q100302054 | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma With Extraintestinal Areas of Peripheral T-Cell Lymphoma Involvement |
| Q50477276 | Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. |
| Q33394912 | Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers |
| Q85205091 | Multiple cranial nerve palsies as the initial presentation of peripheral T-cell lymphoma |
| Q96137703 | Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma |
| Q52739813 | Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy. |
| Q35951772 | Nasal peripheral T-cell lymphoma: a 20-year review of cases treated in Scotland |
| Q67896226 | Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement |
| Q35703714 | New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat |
| Q64043804 | New perspectives in the therapeutic approach of peripheral T-cell lymphoma |
| Q34683488 | New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies |
| Q80938607 | Nodal peripheral T-cell lymphoma associated with Warthin's tumour |
| Q45038000 | Nodal peripheral T-cell lymphoma with secondary granulomatous cutaneous involvement. |
| Q39098289 | Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group |
| Q35661294 | Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study |
| Q44398753 | Non-cytotoxic gamma-delta peripheral T-cell lymphoma affecting the mandibular and parotidal lymph nodes and the skin |
| Q53087981 | Notch signaling in peripheral T-cell lymphoma: revelations from immunohistochemistry. |
| Q30235095 | Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma |
| Q71004110 | Ocular involvement by a peripheral T-cell lymphoma |
| Q52716151 | Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP. |
| Q81371047 | Orbital peripheral T-cell lymphoma in a child |
| Q48105111 | Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study |
| Q48559035 | Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital |
| Q91961254 | Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry |
| Q96578186 | Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients |
| Q47306867 | Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers |
| Q84279702 | Palmoplantar keratoderma as the initial sign in a peripheral T-cell lymphoma |
| Q33428575 | Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial |
| Q35104047 | Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified |
| Q40684809 | Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. |
| Q46718754 | Pediatric malignancies. Case 2. Peripheral T-cell lymphoma in an adolescent with unsuspected Gaucher disease |
| Q37255632 | Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. |
| Q92750209 | Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic Leukemia |
| Q92978049 | Peripheral T-Cell Lymphoma Presenting as Pseudoachalasia |
| Q52711264 | Peripheral T-Cell Lymphoma Presenting as a Primary Uterine Cervix Mass: A Report of a Rare Case. |
| Q61596475 | Peripheral T-Cell Lymphoma With Follicular Involvement and a CD4+/bcl-6+ Phenotype |
| Q40952149 | Peripheral T-Cell Lymphoma in Mediastinum Lymph Nodes and Lung Associated to Histoplasmosis in a Patient with Chronic Lymphoid Leukemia/Small Lymphocytic Lymphoma |
| Q48093925 | Peripheral T-Cell Lymphoma of the Submandibular Salivary Gland as an Unusual Manifestation of Richter's Syndrome: A Case Report and Literature Review |
| Q38143075 | Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review. |
| Q52985713 | Peripheral T-Cell Lymphoma, Not Otherwise Specified and Concurrent Seminoma in Testis. |
| Q39199376 | Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches |
| Q90819698 | Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS) |
| Q70243877 | Peripheral T-Cell Lymphoma: A Clinicopathologic Study of Nine Cases |
| Q40424718 | Peripheral T-Cell Lymphoma: A Posttransplant Lymphoproliferative Disorder Presenting as a Jejunal Mass in a Renal Transplant Recipient |
| Q92957636 | Peripheral T-Cell Lymphoma: Moving Toward Targeted Therapies |
| Q87666296 | Peripheral T-Cell Lymphoma: The Beginning of the End of the Beginning |
| Q35098517 | Peripheral T-Cell lymphoma manifested as gingival enlargement in a patient with chronic lymphocytic leukemia |
| Q58470551 | Peripheral T-cell Lymphoma not Otherwise Specified (PTCL-NOS) in a Patient with Hypereosinophilic Syndrome Showing Multiple Nodules on Chest Computed Tomography |
| Q61737098 | Peripheral T-cell Lymphoma of the Colon: Double-Contrast Barium Enema Examination Findings in Six Patients |
| Q57917606 | Peripheral T-cell Lymphoma of the Eyelid |
| Q36329257 | Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report. |
| Q64240294 | Peripheral T-cell Lymphoma, Not Otherwise Specified: An Unusual Presentation of a Rare Lymphoma |
| Q58763961 | Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation |
| Q53317384 | Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. |
| Q91761576 | Peripheral T-cell lymphoma NOS arising in patients with classical Hodgkin lymphoma of cytotoxic phenotype |
| Q74463855 | Peripheral T-cell lymphoma after anti-CD20 antibody therapy |
| Q36462765 | Peripheral T-cell lymphoma and Job's syndrome: a rare association. |
| Q68042087 | Peripheral T-cell lymphoma and leukemia (description of 4 cases and review of the literature) |
| Q37970850 | Peripheral T-cell lymphoma arising from an intraglandular lymph node in the parotid gland: a case report and literature review |
| Q40573130 | Peripheral T-cell lymphoma arising in the liver |
| Q73888097 | Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome |
| Q40765751 | Peripheral T-cell lymphoma associated with hemophagocytic syndrome |
| Q68606283 | Peripheral T-cell lymphoma associated with hemophagocytic syndrome and hemophagocytic lymphohistiocytosis of children: do they share something? |
| Q40760572 | Peripheral T-cell lymphoma associated with hemophagocytic syndrome: a recently identified entity. Clinico-pathologic and immunohistochemical study of 2 cases |
| Q40183571 | Peripheral T-cell lymphoma at the injection site of influenza vaccination |
| Q47124443 | Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3). |
| Q37908157 | Peripheral T-cell lymphoma classification: the matter of cellular derivation. |
| Q44510934 | Peripheral T-cell lymphoma complicated by a proliferation of large B cells |
| Q33778496 | Peripheral T-cell lymphoma complicated by immunoglobulin A pemphigus: A case report and literature review |
| Q70057564 | Peripheral T-cell lymphoma complicating common variable hypogammaglobulinemia |
| Q85347983 | Peripheral T-cell lymphoma developing after diagnosis of lymphocytic variant hypereosinophilic syndrome: misdiagnosed lymphoma or natural disease progression? |
| Q44335424 | Peripheral T-cell lymphoma developing at ileocolonic anastomosis site after colectomy for adenocarcinoma |
| Q96124246 | Peripheral T-cell lymphoma diagnosis: building a molecular tool |
| Q44011034 | Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate |
| Q53497987 | Peripheral T-cell lymphoma following diffuse large B-cell lymphoma associated with celiac disease. |
| Q77361960 | Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma |
| Q36469010 | Peripheral T-cell lymphoma gene expression profiles. |
| Q37632460 | Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations |
| Q44555896 | Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era. |
| Q52272688 | Peripheral T-cell lymphoma in HIV-positive patients. |
| Q37759336 | Peripheral T-cell lymphoma in Japan: recent progress |
| Q87744286 | Peripheral T-cell lymphoma in a child with cutaneous involvement |
| Q71763526 | Peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient |
| Q79158385 | Peripheral T-cell lymphoma in a five year old |
| Q42915567 | Peripheral T-cell lymphoma in a patient with Crohn's disease |
| Q41763673 | Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome |
| Q74274031 | Peripheral T-cell lymphoma in a patient with osteopetrosis |
| Q68097279 | Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome |
| Q72940038 | Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients |
| Q38808105 | Peripheral T-cell lymphoma in childhood. A clinicopathological study of six cases |
| Q40749769 | Peripheral T-cell lymphoma in childhood: a report of five cases in Taiwan |
| Q51727539 | Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years. |
| Q38050002 | Peripheral T-cell lymphoma in children and adolescents: a single-institution experience |
| Q40628266 | Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation |
| Q40745617 | Peripheral T-cell lymphoma in herpesvirus saimiri-infected tamarins: tumor cell lines reveal subgroup-specific differences |
| Q71952463 | Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice |
| Q34338511 | Peripheral T-cell lymphoma in the canine space: presentation of a case and review of the literature. |
| Q53538734 | Peripheral T-cell lymphoma in the neck: CT findings of lymph node involvement. |
| Q53537225 | Peripheral T-cell lymphoma initially suspected with a single lymphoid aggregate and t(4;16)(q26;p13.3) on bone marrow. |
| Q72625996 | Peripheral T-cell lymphoma involving subcutaneous tissue |
| Q67507321 | Peripheral T-cell lymphoma involving the placenta |
| Q70753177 | Peripheral T-cell lymphoma involving the placenta |
| Q79872872 | Peripheral T-cell lymphoma masquerading as infectious cellulitis |
| Q51776693 | Peripheral T-cell lymphoma mimicking 5-aminosalicylate hypersensitivity in ulcerative colitis. |
| Q87707399 | Peripheral T-cell lymphoma mimicking Schnitzler syndrome |
| Q50115806 | Peripheral T-cell lymphoma mimicking classic Hodgkin's lymphoma in a patient presenting with fevers of unknown origin. |
| Q77932373 | Peripheral T-cell lymphoma mimicking marginal zone B-cell lymphoma |
| Q81120205 | Peripheral T-cell lymphoma not otherwise specified vs. Hodgkin's lymphoma on fine needle aspiration cytology |
| Q43803182 | Peripheral T-cell lymphoma of AILD (angioimmunoblastic lymphadenopathy with dysproteinemia) type involving gastrointestinal tract. A morphologic, phenotypic and genotypic study |
| Q40388333 | Peripheral T-cell lymphoma of Lennert type complicated by monoclonal proliferation of large B-cells |
| Q45819004 | Peripheral T-cell lymphoma of the colon associated with hemophagocytic lymphohistiocytosis |
| Q42090568 | Peripheral T-cell lymphoma of the eyelid |
| Q85214753 | Peripheral T-cell lymphoma of the pleura |
| Q40667576 | Peripheral T-cell lymphoma of the scrotum |
| Q37185825 | Peripheral T-cell lymphoma of tongue: Report of a rare case and review of literature |
| Q69140206 | Peripheral T-cell lymphoma or Hodgkin's disease in a HIV seropositive patient: a histopathological study |
| Q43668546 | Peripheral T-cell lymphoma presenting as Pott's spine |
| Q68095795 | Peripheral T-cell lymphoma presenting as a soft-tissue mass of the extremity |
| Q48136581 | Peripheral T-cell lymphoma presenting as a solitary vermian mass |
| Q37641113 | Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature |
| Q33649392 | Peripheral T-cell lymphoma presenting as ascites: a case report and review of the literature |
| Q69740219 | Peripheral T-cell lymphoma presenting as hemophagocytic syndrome |
| Q68091599 | Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis |
| Q79446766 | Peripheral T-cell lymphoma presenting as lipoatrophy and nodules |
| Q82210793 | Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor |
| Q68901310 | Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases |
| Q81348259 | Peripheral T-cell lymphoma presenting as sclerouveitis |
| Q43225115 | Peripheral T-cell lymphoma presenting as testicular mass; a diagnostic challenge |
| Q68100670 | Peripheral T-cell lymphoma presenting with angioedema and diffuse pulmonary infiltrates |
| Q93207516 | Peripheral T-cell lymphoma presenting with pleural effusion |
| Q33347445 | Peripheral T-cell lymphoma presenting with rapidly progressing myelofibrosis |
| Q80984686 | Peripheral T-cell lymphoma resembling Kimura's disease |
| Q40812586 | Peripheral T-cell lymphoma simulating Hodgkin's disease with initial bone marrow involvement |
| Q37829843 | Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease |
| Q80376824 | Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-beta1 |
| Q61774252 | Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study |
| Q38868024 | Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review |
| Q40372095 | Peripheral T-cell lymphoma unspecified with remarkably extensive airspace consolidations and ground-glass opacities of bilateral lung fields |
| Q40271392 | Peripheral T-cell lymphoma with EBV-infected "anaplastic" B-cell proliferation confined to sinuses. |
| Q28145960 | Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection |
| Q41665023 | Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases |
| Q81410828 | Peripheral T-cell lymphoma with a "follicular" pattern and the perifollicular sinus phenotype |
| Q40579286 | Peripheral T-cell lymphoma with a nodular growth pattern |
| Q37916156 | Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru. |
| Q35565675 | Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20 |
| Q32112496 | Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall |
| Q69736684 | Peripheral T-cell lymphoma with bilateral submandibular lymphadenopathy |
| Q53549526 | Peripheral T-cell lymphoma with diffuse pulmonary infiltration and an increase in serum KL-6 level. |
| Q73347789 | Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? |
| Q64042868 | Peripheral T-cell lymphoma with endobronchial involvement |
| Q54779591 | Peripheral T-cell lymphoma with eosinophilia presenting as monoarthritis: a case study. |
| Q42183621 | Peripheral T-cell lymphoma with epstein-barr virus-positive reed-sternberg-like B-cells in a 59-year-old Hispanic man. |
| Q45161572 | Peripheral T-cell lymphoma with erysipelaslike spread. |
| Q80064778 | Peripheral T-cell lymphoma with extensive dendritic cell network mimicking follicular dendritic cell tumor: a case report with pathologic, immunophenotypic, and molecular findings |
| Q42596850 | Peripheral T-cell lymphoma with follicular T-cell markers |
| Q79428254 | Peripheral T-cell lymphoma with gamma/delta phenotype clinically presents with splenomegaly |
| Q90166759 | Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract |
| Q46123973 | Peripheral T-cell lymphoma with granulomatous reaction |
| Q70067644 | Peripheral T-cell lymphoma with helper T-cell phenotype (Leu 3a+ Leu 8-) |
| Q38272984 | Peripheral T-cell lymphoma with hypercalcemic crisis as a primary symptom accompanied by polymyositis: A case report and review of the literature |
| Q57759658 | Peripheral T-cell lymphoma with involvement of the expanded mantle zone |
| Q40127790 | Peripheral T-cell lymphoma with left ankle swelling, ulceration and fever |
| Q45373467 | Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone |
| Q46841109 | Peripheral T-cell lymphoma with secondary epithelioid granulomatous cutaneous involvement: a clinicopathologic study of four cases |
| Q50477659 | Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly. |
| Q41575559 | Peripheral T-cell lymphoma with unique immunologic features |
| Q44126164 | Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis |
| Q60019709 | Peripheral T-cell lymphoma – are we making progress? |
| Q40241614 | Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma |
| Q39099548 | Peripheral T-cell lymphoma, not otherwise specified |
| Q47112210 | Peripheral T-cell lymphoma, not otherwise specified |
| Q51812688 | Peripheral T-cell lymphoma, not otherwise specified accompanied by central nervous system involvement with features of lymphomatosis cerebri. |
| Q86949602 | Peripheral T-cell lymphoma, not otherwise specified presenting with multiple tender cutaneous nodules and plaques |
| Q85888389 | Peripheral T-cell lymphoma, not otherwise specified with prominent cutaneous involvement |
| Q58803558 | Peripheral T-cell lymphoma, not otherwise specified, presenting with generalized ulcerated plaques and hypereosinophilia |
| Q96607323 | Peripheral T-cell lymphoma, not otherwise specified- Case report |
| Q33393849 | Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project |
| Q50202911 | Peripheral T-cell lymphoma, not otherwise specified: a retrospective single-center analysis. |
| Q31121474 | Peripheral T-cell lymphoma, unspecified--the analysis of the data from the Czech Lymphoma Study Group (CLSG) registry. |
| Q37874108 | Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management. |
| Q53388032 | Peripheral T-cell lymphoma: a challenging mimicker of angioedema and urticaria. |
| Q44880240 | Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases |
| Q69906455 | Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases |
| Q55241412 | Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification. |
| Q77467808 | Peripheral T-cell lymphoma: a developing concept |
| Q70080191 | Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes |
| Q37777597 | Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy |
| Q69387456 | Peripheral T-cell lymphoma: clinicopathologic analyses of 25 cases |
| Q43580277 | Peripheral T-cell lymphoma: diagnosis and treatment |
| Q86255027 | Peripheral T-cell lymphoma: frequency and distribution in a tertiary referral center in South India |
| Q38166756 | Peripheral T-cell lymphoma: new therapeutic strategies |
| Q49683429 | Peripheral T-cell lymphoma: novel backbone |
| Q34479082 | Peripheral T-cell lymphoma: review and updates of current management strategies |
| Q35047820 | Peripheral T-cell lymphoma: spectrum of imaging findings with clinical and pathologic features |
| Q38145944 | Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation |
| Q46299501 | Peripheral T-cell lymphoma: time for a T-cell-centric standard of care |
| Q95477432 | Peripheral T-cell lymphoma: what's the role for transplant? |
| Q87311007 | Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab |
| Q33394324 | Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma |
| Q100534033 | Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea |
| Q83002044 | Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma |
| Q86603764 | Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma |
| Q90929995 | Phase II Trial Using Romidepsin after Gemcitabine, Dexamethasone, and Cisplatin Therapy in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Study Protocol |
| Q33425087 | Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma |
| Q86395806 | Phenotypic evolution in a case of peripheral T-cell lymphoma suggests the presence of tumor heterogeneity |
| Q43103123 | Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. |
| Q39028883 | Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. |
| Q72775927 | Polymerase chain reaction amplification analyses of clonality in T-cell malignancy including peripheral T-cell lymphoma |
| Q45351675 | Polymyositis as a paraneoplastic syndrome in cytotoxic molecule-positive and Epstein-Barr virus-associated peripheral T-cell lymphoma, not otherwise specified |
| Q37253554 | Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma |
| Q110661788 | Population-Based Analysis of Elderly Patients (>70 YEARS) with Peripheral T-CELL Lymphoma: A Results from Czech Lymphoma Study Group (CLSG) Registry |
| Q84560987 | Pralatrexate (Folotyn) for peripheral T-cell lymphoma |
| Q92711628 | Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin |
| Q64059254 | Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study |
| Q33393701 | Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study |
| Q92200798 | Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment |
| Q94483340 | Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment: Erratum |
| Q91954512 | Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma |
| Q37940292 | Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses |
| Q73443100 | Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma |
| Q50231478 | Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients. |
| Q41466994 | Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis. |
| Q36038466 | Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma. |
| Q88529267 | Primary Cutaneous Peripheral T-Cell Lymphoma in a Sporotrichoid Pattern: A Case Report |
| Q90731444 | Primary Cutaneous Peripheral T-Cell Lymphoma of the Hand: Case Report of a Rare Diagnosis and Review of the Literature |
| Q92044428 | Primary High-grade Peripheral T-cell Lymphoma of the Testis Clinically Confused With Scrotal Abscess |
| Q37206484 | Primary Uterine Peripheral T-cell Lymphoma: A Case Report of MRI and 18F-FDG PET/CT Findings |
| Q50902498 | Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell lymphoma (PTCL) NOS. |
| Q74394341 | Primary bony peripheral T-cell lymphoma mimicking nasal type NK/T-cell lymphoma: a case report |
| Q34690890 | Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case |
| Q48145530 | Primary central nervous system peripheral T-cell lymphoma in a child |
| Q37988862 | Primary composite lymphoma of the larynx, composed of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, presenting as left subglottic tracheal fistula, esophageal diverticulum, and neck abscess. |
| Q42193123 | Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia |
| Q61053533 | Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases |
| Q53450750 | Primary cutaneous peripheral T-cell lymphoma in a patient with X-linked agammaglobulinaemia |
| Q56395283 | Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma |
| Q93378180 | Primary cutaneous peripheral T-cell lymphoma with a late relapse solely in the ileum mimicking monomorphic epitheliotropic intestinal T-cell lymphoma |
| Q37422903 | Primary cutaneous peripheral T-cell lymphoma with aberrant coexpression of CD20: case report and review of the literature |
| Q100391892 | Primary cutaneous peripheral T-cell lymphoma, not otherwise specified (NOS): results of a multicenter EORTC cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features |
| Q104283567 | Primary cutaneous peripheral T-cell lymphoma, not otherwise specified with mammalian target of rapamycin mutation: A novel finding for targeted treatment |
| Q93171266 | Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report |
| Q37747831 | Primary cutaneous peripheral T-cell lymphoma, unspecified with an indolent clinical course: a distinct peripheral T-cell lymphoma? |
| Q79740627 | Primary cutaneous peripheral T-cell lymphoma, unspecified, that completely regressed after skin biopsy |
| Q79319163 | Primary cutaneous peripheral T-cell lymphoma, unspecified, with CD8-positive phenotype |
| Q90702477 | Primary epiglottic follicular variant of peripheral T-cell lymphoma |
| Q40122318 | Primary hepatic Epstein-Barr virus-associated CD30-positive peripheral T-cell lymphoma of cytotoxic phenotype |
| Q52727262 | Primary hepatic peripheral T-cell lymphoma associated with Epstein-Barr viral infection. |
| Q84343067 | Primary hepatic peripheral T-cell lymphoma in a patient with chronic hepatitis B infection |
| Q41486161 | Primary hepatic peripheral T-cell lymphoma mimicking hepatocellular carcinoma: a case report |
| Q37855416 | Primary hepatic peripheral T-cell lymphoma treated with corticosteroid. |
| Q33778463 | Primary hepatic peripheral T-cell lymphoma: A case report |
| Q81229227 | Primary orbital peripheral T-cell lymphoma: histologic, immunophenotypic, and genotypic features |
| Q80415749 | Primary peripheral T-cell lymphoma in subcutaneous tissue: sonographic findings |
| Q48692452 | Primary peripheral T-cell lymphoma of the acoustic nerve |
| Q74649774 | Primary peripheral T-cell lymphoma of the acoustic nerve |
| Q81024816 | Primary peripheral T-cell lymphoma of the central nervous system |
| Q53221380 | Primary peripheral T-cell lymphoma of the colon mimics inflammatory bowel disease: a potential pitfall with F-18 FDG PET/CT imaging. |
| Q43466967 | Primary peripheral T-cell lymphoma of the face other than mycosis fungoides. Computed tomography and magnetic resonance findings |
| Q43295093 | Primary peripheral T-cell lymphoma of the orbit |
| Q86187044 | Primary peripheral T-cell lymphoma, not otherwise specified of the thyroid with autoimmune thyroiditis |
| Q52150024 | Primary peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child. |
| Q36439284 | Primary pulmonary peripheral T-cell lymphoma: A case report and review of the literature |
| Q59131957 | Primary sino-orbital peripheral T-cell lymphoma presenting as unilateral periorbital swelling: a case report |
| Q34434810 | Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma |
| Q57468383 | Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma |
| Q44167264 | Prognostic Value of the Histologic Classification of Peripheral T-cell Lymphoma: A Clinico-Pathologic Study of 71 HTLV-1 Negative Cases |
| Q90414822 | Prognostic Values of Baseline 18F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma |
| Q91873137 | Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia |
| Q44051292 | Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study |
| Q42075630 | Prognostic factors of peripheral T-cell lymphoma (PTL): statistical analysis on 30 patients |
| Q34166857 | Prognostic markers in peripheral T-cell lymphoma |
| Q45413496 | Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. |
| Q41913876 | Prognostic significance of [18F]fluorodeoxyglucose-positron emission tomography in peripheral T-cell lymphoma treated with stem cell transplantation: a retrospective analysis |
| Q35232775 | Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma |
| Q52985576 | Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL). |
| Q93187782 | Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma |
| Q37088457 | Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System |
| Q46051838 | Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation. |
| Q99348104 | Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma |
| Q57025282 | Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified |
| Q89023994 | Pseudomonas oryzihabitans bacteremia in a child with peripheral T-cell lymphoma after allogeneic bone marrow transplantation |
| Q41568274 | Pulmonary involvement of peripheral T-cell lymphoma manifesting as crazy paving pattern. |
| Q53450129 | Pulmonary manifestations of peripheral T-cell lymphoma: case report and review of the literature. |
| Q85642901 | Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified |
| Q37350788 | Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States |
| Q91304792 | Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma |
| Q40102773 | Rapid Evolving Unilateral Indurated Oozing Facial Plaques in a Patient with Head-and-Neck Cancer: Peripheral T-Cell Lymphoma Not Otherwise Specified (NOS). |
| Q40080785 | Rapid Fatal Acute Peripheral T-Cell Lymphoma Associated With IgG Plasma Cell Leukemia and IgA Hypergammaglobulinemia. |
| Q41607082 | Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy |
| Q85006355 | Rapid neurologic decline in a patient with peripheral T-cell lymphoma: a case of leptomeningeal lymphomatosis |
| Q58576094 | Rapidly progressive renal failure due to tubulointerstitial infiltration of peripheral T-cell lymphoma, not otherwise specified accompanied by uveitis: a case report |
| Q95837492 | Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma |
| Q92478109 | Re: Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma |
| Q42834405 | Recent advance in peripheral T-cell lymphoma, not otherwise specified |
| Q42960607 | Recent advance in peripheral T-cell lymphoma, not otherwise specified |
| Q87417473 | Recurrence of peripheral T-cell lymphoma as granulomas in the lower limbs |
| Q52925668 | Recurrent CD4-/CD8- peripheral T-cell lymphoma with change in cytoarchitectural features and immunophenotype over the course of disease. |
| Q89777500 | Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma |
| Q50045613 | Refractory CD20-positive peripheral T-cell lymphoma showing loss of CD20 expression after rituximab therapy and gain of CD20 expression after administration of vorinostat and gemcitabine |
| Q90328377 | Refractory Septic Shock due to Underlying Immunocompromised Disease: A Case of Fatal Peripheral T-Cell Lymphoma Not Otherwise Specified in a Young Hispanic Woman |
| Q90734242 | Relapsed refractory nodal peripheral T-cell lymphoma with follicular helper T-cell phenotype was initially resistant to pralatrexate and confirmed to be unresponsive to subsequent forodesine, but responded to re-instituted pralatrexate |
| Q90666198 | Relapsed, refractory peripheral T-cell lymphoma not otherwise specified successfully treated with allogeneic haematopoietic stem cell transplantation |
| Q37609238 | Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma |
| Q33423854 | Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma |
| Q33399309 | Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy |
| Q79839157 | Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901 |
| Q44150917 | Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified. |
| Q73397790 | Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome |
| Q51607447 | Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan. |
| Q40242816 | Rhabdomyolysis caused by peripheral T-cell lymphoma in skeletal muscle |
| Q95930918 | Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma Not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature |
| Q79814567 | Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified |
| Q101048470 | Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma |
| Q110661996 | Role of Single Agent and Combination Chemotherapy Strategies in Relapsed/Refractory Peripheral T-Cell Lymphoma: Results from the Complete Registry |
| Q73227606 | Role of apoptosis in spontaneous regression of peripheral T-cell lymphoma arising in the skin or subcutis |
| Q47290596 | Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers |
| Q26785732 | Romidepsin for the Treatment of Peripheral T-Cell Lymphoma |
| Q33592768 | Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses |
| Q33443153 | Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study. |
| Q38379898 | Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials |
| Q95381234 | Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials |
| Q61810073 | Rosai Dorfman disease and peripheral T-cell lymphoma: A rare co-occurrence |
| Q36283958 | Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphoma |
| Q48650246 | Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study |
| Q92768908 | Secondary Cutaneous Dissemination of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype as a Patient's Fourth Primary Malignancy |
| Q39152184 | Secondary cutaneous peripheral T-cell lymphoma, unspecified, with generalized benign-looking dermatitis: a possibly distinct peripheral T-cell lymphoma |
| Q80426226 | Sequential development of large B cell lymphoma in a patient with peripheral T-cell lymphoma |
| Q68920790 | Sequential development of peripheral T-cell lymphoma in the course of chronic myelogenous leukemia |
| Q40300949 | Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma |
| Q39659168 | Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified |
| Q81557250 | Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U) |
| Q81737851 | Severe atherosclerosis of the aorta and development of peripheral T-cell lymphoma in an adolescent with angiolymphoid hyperplasia with eosinophilia |
| Q38046051 | Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long |
| Q56995316 | Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma. Report of 2 cases |
| Q92525267 | Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry |
| Q92484186 | Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis |
| Q67599979 | Specific cutaneous lesions in a CD8+ peripheral T-cell lymphoma |
| Q84769649 | Stem cell transplantation for paediatric patients with non-anaplastic peripheral T-cell lymphoma in Japan |
| Q37391571 | Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve |
| Q84768243 | Striking morphology of leukemic phase of childhood peripheral T-cell lymphoma, not otherwise specified |
| Q91919316 | Subclassifying peripheral T-cell lymphoma NOS |
| Q80501555 | Submassive hepatocellular necrosis associated with infiltration by peripheral T-cell lymphoma of cytotoxic phenotype: report of two cases |
| Q55266887 | Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy. |
| Q42283591 | Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy |
| Q57279971 | Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL) |
| Q98196607 | Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression |
| Q44250160 | Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation |
| Q79760188 | Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide |
| Q43550405 | Survival advantage with the addition of radiation therapy to chemotherapy in early stage peripheral T-cell lymphoma, not otherwise specified |
| Q40679472 | Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database |
| Q43609761 | Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors |
| Q59187250 | Synchronous Advanced Scrotal Verrucous Carcinoma with Peripheral T-Cell Lymphoma |
| Q45951570 | Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumor lysis in a patient with peripheral T-cell lymphoma unspecified. |
| Q100407042 | T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma |
| Q38124725 | T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway |
| Q33387776 | THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study |
| Q84959078 | Tale of two lymphomas: peripheral T-cell lymphoma after allogeneic stem-cell transplantation for marginal zone lymphoma |
| Q43094875 | Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis. |
| Q73905978 | Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL |
| Q40241074 | The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL). |
| Q93094076 | The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores |
| Q51662338 | The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. |
| Q58010789 | The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature |
| Q77419654 | The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma |
| Q38287014 | The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified |
| Q38182249 | The changing landscape of peripheral T-cell lymphoma in the era of novel therapies |
| Q37465153 | The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers? |
| Q48301800 | The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers. |
| Q43074721 | The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma. |
| Q52651164 | The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience. |
| Q49085795 | The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. |
| Q40789766 | The occurrence of a peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient. |
| Q35607281 | The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma |
| Q52620959 | The outcome of peripheral T-cell lymphoma patients failing first line therapy: a report from the prospective, international T-Cell project. |
| Q64092493 | The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project |
| Q86874075 | The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma |
| Q91317469 | The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma |
| Q53132335 | The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. |
| Q42608320 | The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma |
| Q91757708 | The prognostic value of platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in the treatment response and survival of patients with peripheral T-cell lymphoma |
| Q53243269 | The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. |
| Q38006171 | The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: a review of the literature and new perspectives |
| Q89371038 | The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature |
| Q69001565 | The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia |
| Q52873834 | The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function. |
| Q51738087 | Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma: A case report and literature review. |
| Q87537890 | Therapeutic effects and influencing factors in sixty-eight cases of peripheral T-cell lymphoma unspecified |
| Q26748857 | Therapeutic options in peripheral T cell lymphoma |
| Q33505113 | Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients |
| Q83184967 | Thickening of multiple cranial nerves in a patient with extranodal peripheral T-cell lymphoma |
| Q33670421 | Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma |
| Q52571141 | Transformation of T-Cell Acute Lymphoblastic Lymphoma to Peripheral T-Cell Lymphoma: A Report of Two Cases. |
| Q64041708 | Transplantation |
| Q52859294 | Treatment of Peripheral T-Cell Lymphoma in Community Settings. |
| Q26797507 | Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray |
| Q30613674 | Treatment of peripheral T-cell lymphoma: are we data driven or driving the data? |
| Q77805702 | Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK) |
| Q47256653 | Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma |
| Q83226259 | Unspecified solitary peripheral T-cell lymphoma of the breast in a teenaged girl |
| Q37804658 | Unusual Skin Lesions Mimicking Bruises Caused by Pseudomonas Septicemia Secondary to Undiagnosed Peripheral T-Cell Lymphoma in a Young Woman |
| Q73959250 | Unusual locations for lymphomas. Case 3. Successive occurrence of peripheral T-cell lymphoma with bilateral conjuctival involvement in a patient with low-grade B-cell lymphoma |
| Q84248537 | Unusual manifestation of histiocyte-rich peripheral T-cell lymphoma |
| Q58033666 | Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 |
| Q85953465 | Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center |
| Q92547558 | Use of Complete Blood Count for Prognostic Evaluation of Peripheral T-Cell Lymphoma |
| Q54202645 | Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. |
| Q90289188 | Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma |
| Q91557800 | Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified |
| Q92144086 | [A Case of Metastatic Peripheral T-cell Lymphoma of the Central Nervous System During the Perinatal Period] |
| Q71616507 | [A case of CD56-positive peripheral T-cell lymphoma presenting with giant tumor of the gastrointestinal tract during the course] |
| Q74617103 | [A case of unclassifiable peripheral T-cell lymphoma] |
| Q95623945 | [Advances in diagnosis and treatment of peripheral T-cell lymphoma and its translational research] |
| Q81111353 | [Array comparative genomic hybridilyzation analysis for unclassified peripheral T-cell lymphoma revealed possible subgrouping] |
| Q68814903 | [Association of peripheral T-cell lymphoma in a patient with Sjögren's syndrome] |
| Q53177039 | [CD20(+) peripheral T-cell lymphoma: clinicopathologic analyses of three cases and literatures review]. |
| Q84970585 | [CD20-positive peripheral T-cell lymphoma, not otherwise specified] |
| Q93175622 | [Chidamide combined with chemotherapy for treatment of therapy-related acute myeloid leukemia secondary to peripheral T-cell lymphoma: a case report and literatures review] |
| Q91988624 | [Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Peripheral T-Cell Lymphoma] |
| Q85509695 | [Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation] |
| Q87256603 | [Clinical efficacy of dexamethasone, methotrexate combined with cyclophosphamide for treatment of patients with peripheral T-cell lymphoma] |
| Q81064314 | [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen] |
| Q80430777 | [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen] |
| Q58127199 | [Clinical outcomes of peripheral blood stem cell transplantation for aggressive peripheral T-cell lymphoma] |
| Q83960388 | [Clinical significance of survivin expression in peripheral T-cell lymphoma] |
| Q54474793 | [Clinicopathologic features of peripheral T-cell lymphoma, unspecified with follicular pattern]. |
| Q72549490 | [Clinicopathological analysis of midline peripheral T-cell lymphoma] |
| Q90592317 | [Current standard in diagnostic and therapy of peripheral T-cell lymphoma] |
| Q85384862 | [Diagnosis and treatment of peripheral T-cell lymphoma] |
| Q92236475 | [Evaluation of clinical outcomes of allogeneic hematopoietic stem cell transplantation for relapsed/refractory peripheral T-cell lymphoma with chemoresistance] |
| Q79430779 | [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma] |
| Q96118606 | [Expression of CDK6 and FOXM1 in peripheral T-cell lymphoma and their significance] |
| Q79629892 | [Expression of survivin and NF-kappaB in peripheral T-cell lymphoma and its significance] |
| Q54601822 | [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases]. |
| Q72385035 | [Hemifacial malignant granuloma as clinical manifestation of peripheral T-cell lymphoma] |
| Q91864217 | [Heterogeneity of genomic alterations and clinical aspects in peripheral T-cell lymphoma: future perspectives] |
| Q90350271 | [III. Novel Agents for Peripheral T-Cell Lymphoma] |
| Q86082906 | [Mutations in epigenetic and metabolic regulators in peripheral T-cell lymphoma] |
| Q95530802 | [Peripheral T-Cell Lymphoma, Not Otherwise Specified Occurring After the Treatment of Relapsed Follicular Lymphoma] |
| Q78236732 | [Peripheral T-cell lymphoma 9 months after hemophagocytic syndrome with a favorable outcome after splenectomy] |
| Q55242130 | [Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis] |
| Q79440025 | [Peripheral T-cell lymphoma presenting with eosinophilia due to interleukin-5 produced by lymphoma cells] |
| Q55240767 | [Peripheral T-cell lymphoma with abundant ATL-like cells in the blood] |
| Q96946639 | [Peripheral T-cell lymphoma with follicular helper of T cell phenotype of Waldeyer's ring: a clinicopathological and genetic study of eight cases] |
| Q82716680 | [Peripheral T-cell lymphoma, NOS arising in Warthin tumor: report of a case] |
| Q95581324 | [Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)] |
| Q80131150 | [Peripheral T-cell lymphoma: diagnosis and treatment] |
| Q101455681 | [Present and future perspective of the treatment of peripheral T-cell lymphoma] |
| Q83710171 | [Primary cutaneous peripheral T-cell lymphoma (not otherwise specified)] |
| Q83059734 | [Primary peripheral T-cell lymphoma of the penis: a case report and review of the literature] |
| Q53179403 | [Primary peripheral T-cell lymphoma of the vagina incidentally found at cervical cancer screening]. |
| Q89762552 | [Prognostic significance of NCCN-International Prognostic Index (NCCN-IPI) for patients with peripheral T-cell lymphoma treated with CHOP-based chemotherapy] |
| Q82853330 | [Prostatic granulomas revealing a peripheral T-cell lymphoma] |
| Q92422426 | [Relapsed acute myeloid leukemia concomitant with TET2-mutated peripheral T-cell lymphoma, not otherwise specified] |
| Q45941018 | [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis]. |
| Q53086073 | [Successful therapy for enteropathy-associated peripheral T-cell lymphoma using high-dose polychemotherapy and autologous hematopoietic stem cell transplantation]. |
| Q73834882 | [Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation] |
| Q88515436 | [T-bet in peripheral T-cell lymphoma] |
| Q73555863 | [The efficacy of L-asparaginase in the treatment of refractory midline peripheral T-cell lymphoma] |
| Q55239047 | [The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL]. |
| Q87965759 | [Treatment of peripheral T-cell lymphoma] |
| Q34667550 | c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors |
| Q43916739 | gamma/delta peripheral T-cell lymphoma of the breast diagnosed by fine-needle aspiration biopsy |
| Q68822493 | ins(6;11) in a case of peripheral T-cell lymphoma |
| Q90087562 | nm23, TOP2A and VEGF expression: Potential prognostic biologic factors in peripheral T-cell lymphoma, not otherwise specified |
| Q45757680 | t(3;17)(q21;q25) in Epstein-Barr virus associated peripheral T-cell lymphoma: a paediatric case. |
| Q28371108 | IDH2 R172 | positive diagnostic predictor for | P3356 |
| Q28371108 | IDH2 R172 | positive prognostic predictor for | P3358 |
| Q113098603 | Daniel Chorley | cause of death | P509 |